Results 1 to 20 of 33
Page 1 of 2  Next >
TypeTitleAuthor(s)YearViews
Prevalence and time trend of intestinal metaplasia in Hong KongYee, YK; Wong, KW; Hui, CK; Chan, CK; Chan, AOO; Lam, SK; Fung, FMY; Hung, I; Wong, BCY2009173
 
Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapyGu, Q; Xia, HHX; Wang, JD; Wong, WM; Chan, AOO; Lai, KC; Chan, CK; Yuen, MF; Fung, FMY; Wong, KW; Lam, SK; Wong, BCY2006109
 
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infectionWong, WM; Gu, Q; Chu, KM; Yee, YK; Fung, FMY; Tong, TSM; Chan, AOO; Lai, KC; Chan, CK; Wong, BCY2006143
 
Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patientsWong, WM; Huang, J; Xia, HHX; Fung, FMY; Tong, TSM; Cheung, KL; Ho, VYK; Lai, KC; Chan, CK; Chan, AOO; Hui, CK; Lam, SK; Wong, BCY2005116
 
Natural acquisition of Helicobacter pylori in adult dyspeptic patients with or without previous infection – a 7-year follow-up study. Australian Gastroenterology Week 2005, 19 October 2005, Australia.Xia, HHX; Wong, RWM; Chan, OO; Lam, SK; Lai, KC; Chan, CK; Cheung, KL; Fung, FMY; Wong, KW; Wong, BCY200585
 
Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy.Gu, Q; Xia, HHX; Wang, J; Chan, OO; Lai, KC; Fung, FMY; Wong, KW; Cheung, KL; Kung, H; Wong, BCY2005117
 
Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong KongXia, B; Xia, HHX; Ma, CW; Wong, KW; Fung, FMY; Hui, CK; Chan, CK; Chan, AOO; Lai, KC; Yuen, MF; Wong, BCY2005257
 
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infectionWong, WM; Gu, O; Lam, SK; Fung, FMY; Lai, KC; Hu, WHC; Yee, YK; Chan, CK; Xia, HHX; Yuen, MF; Wong, BCY200384
 
Effects of Primary Metronidazole and Clarithromycin Resistance to Helicobacter pylori on Omeprazole, Metronidazole, and Clarithromycin Triple-Therapy Regimen in a Region with High Rates of Metronidazole ResistanceWong, WM; Gu, Q; Wang, WH; Fung, FMY; Berg, DE; Lai, KC; Xia, HHX; Hu, WHC; Chan, CK; Chan, AOO; Yuen, MF; Hui, CK; Lam, SK; Wong, BCY2003453
 
Randomised controlled study of rabeprazole, levofloxacin and rifabutin triple therapy versus quadruple therapy as second-line treatment of Helicobacter pylori infectionWong, WM; Gu, Q; Lam, SK; Fung, FMY; Lai, KC; Hu, WHC; Yee, YK; Chan, CK; Xia, HHX; Yuen, MF; Wong, BCY2003213
 
Randomized controlled trial of rabeprazole, levofloxacin and rifabutin triple therapy versus rabeprazole-based quadruple therapy as a rescue treatment for failure of Helicobacter pylori eradication with standard tiple therapiesWong, WM; Gu, Q; Lam, SK; Fung, FMY; Lai, KC; Xia, HHX; Hu, HC; Wong, BCY200282
 
Optimal serological tests for the detection of Helicobacter pylori infection in the Chinese populationXia, HHX; Wong, BCY; Wong, WM; Tang, VSY; Cheung, HKL; Sham, FNF; Fung, FMY; Lai, KC; Hu, WHC; Chan, CK; Lam, SK200273
 
One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapiesWong, WM; Wong, BCY; Lu, H; Gu, Q; Yin, Y; Wang, WH; Fung, FMY; Lai, KC; Xia, HHX; Xiao, SD; Lam, SK200293
 
Evaluation of three near patient tests for the diagnosis of Helicobacter pylori (H. pylori) infection in Chinese populationWong, WM; Wong, BCY; Tang, VSY; Wong, KW; Li, TM; Cheung, KL; Fung, FMY; Lai, KC; Hu, WHC; Chan, CK; Xia, HHX; Lam, SK2002205
 
Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patientsWong, WM; Wong, BCY; Hung, WK; Yee, YK; Yip, AWC; Szeto, ML; Fung, FMY; Tong, TSM; Lai, KC; Hu, WHC; Yuen, MF; Lam, SK2002305
 
One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in ChineseHung, WK; Wong, WM; Wong, GSW; Yip, AWC; Szeto, ML; Lai, KC; Hu, WHC; Chan, CK; Xia, HHX; Yuen, MF; Fung, FMY; Tong, TSM; Ho, VYK; Lam, SK; Wong, BCY2002175
 
One week omeprazole, furazolidone and amoxycillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapiesGu, Q; Wong, WM; Lam, SK; Yin, Y; Wang, WH; Fung, FMY; Lai, KC; Xia, HHX; Wong, BCY; Xiao, SD200286
 
Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infectionWong, BCY; Wong, WM; Yee, YK; Hung, WK; Yip, AWC; Szeto, ML; Li, KF; Lau, P; Fung, FMY; Tong, TSM; Lai, KC; Hu, WHC; Yuen, MF; Hui, CK; Lam, SK2001102
 
Low dose 13C-urea breath test with citrate is equally reliable for the detection of Helicobacter pylori infection in ChineseWong, KW; Wong, WM; Lam, SK; Li, TM; Cheung, KL; Fung, FMY; Xia, HHX; Wong, BCY200164
 
Epidermal growth factor and its receptor in chronic active gastritis and gastroduodenal ulcer before and after Helicobacter pylori eradicationWong, BCY; Wang, WP; So, WHL; Shin, VY; Wong, WM; Fung, FMY; Liu, ESL; Hiu, WM; Lam, SK; Cho, CH200191
 
Page 1 of 2  Next >
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download